ClinicalTrials.gg
RecruitingNCT06563206Updated Aug 20, 2024

Exergame and Robotic Therapy Impact on Tenascin-C and Functional Outcome on Stroke Patients

An interventional study of Exergame and Robotic in Stroke and Paralysis Arm, sponsored by Hasanuddin University. Recruiting at 2 sites in Indonesia. Per ClinicalTrials.gov, last updated 2024-08-20.

Sponsored by Hasanuddin University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Registered 10 months after the study started (first participant enrolled Oct 2023, registered Aug 2024).
  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Stroke with a site in Indonesia — 7 open to participants now, 8 under way, none of them phase 3. Stroke · Indonesia.

Planned enrollment
5th of 10
48 · median 44
Started
2023
with 2 others
No phase
7 of 13
6 open now
Registered
9th of 13
by date
Lead sponsor
2 of 13
Hasanuddin University

Among the 13 studies in Stroke with a site in Indonesia, this one is the 5th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2023, is one of 7 with no phase, and was the 9th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

7 of the 13 studies in Stroke with a site in Indonesia are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stroke with a site in Indonesia, or all of them as a file.
02

Study summary

This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are:

1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions

Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome

Read the detailed description

1, Research design This research is an experimental study with a randomized controlled trial research design.

  1. Study Setting The research will be carried out among post-stroke patients at two teaching hospitals and one physical rehabilitation center in Makassar
  1. Procedure

a. Standard Rehabilitation Comprehensive medical management and rehabilitation of disabilities caused by stroke through the neurorehabilitation approach with the aim of optimizing recovery and or modifying existing remaining symptoms so that stroke people are able to carry out functional activities independently, can adapt to the environment and achieve quality life

b. Exergame Physical exercise of the entire body carried out through active video games that require gross motor skills, visual-spatial coordination, balance, and energy expenditure that are proportional to the intensity of moderate physical activity

c. Robotic Therapy Mirror therapy intervention uses the help of robot exoskeletal to move the sick side. A set of mirror therapy exercises, using Syrebo robotics, using 1 set of Activity Daily Living (ADL) training during therapy, and using a mirror that will reflect a healthy side shadow.

  1. Time frame the procedure will be conducted in parallel three times per week for a total of six weeks, with two measurements before and after six weeks of training
  1. Outcomes
  1. motoric ability of upper extremity using Fugl-Meyer Assessment for Upper Extremities (FMA-UE)
  2. Dexterity, coordination and response of finger using the Nine Hole Peg Test (NHPT)
  3. Hand motor strength with Handgrip dynamometer
  4. Level of Tenascin-C in blood serum before and after

    1. Case definition

a. type of stroke determined by radiology imaging b. phase of stroke (acute, sub-acute or chronic) c. cognitive ability measured using mini-mental state examination (MMSE) d. Spasticity measured by the Modified Ashworth Scale (MAS)

  1. Procedure

a. The data collected is primary data obtained in accordance with the inclusion criteria.

b. Samples who are willing to become research subjects will undergo interviews, physical examinations, FMA-UE-Hand Motor Domain, handgrip and NHPT examinations. The interview questionnaire in this study will contain a list of patient identities including name, age, marital status, address, educational history, employment history, history of stroke, cognitive examination (MMSE), and self-reported visual ability.

  1. Measurement tools
  1. The FMA-UE-Hand Motor Domain scoring system is used to evaluate upper extremity motor function in patients with neurological disorders, such as stroke. The scoring system ranges from 0-14, with higher scores indicating better motor function. The FMA-UE-Hand Motor domain assessment system is broken down into several subscales, namely Mass Flexion and Extension movements, followed by functional movements of grasping (Grasp), including Hook Grasp, Thumb Adduction, Pincer Grasp, Cylinder Grasp, and Spherical Grasp. The assessment will get a score of 0 = None or no movement, 1 = Partial or limited movement, and 2 = Full or perfect movement.
  2. The NHPT assessment consists of a square board with 9 pegs. At one end of the board, there is a hole for the peg, and at the other end, there is a shallow round plate for holding the peg. NHPT is performed by having the patient take pegs from a container, one at a time, and place them into the holes in a board, as quickly as possible. The patient must then remove the pegs from the holes, one at a time, and reinsert them into the housing. To practice and register initial scores, the test must be started with the unaffected upper limb. The board should be placed in the centre of the patient's body with the housing holding the pegs oriented toward the hand being tested. Only the hand being evaluated should perform the test. The non-evaluated hand is allowed to grip the edge of the board to provide stability. Patients are scored based on the time required to complete the test activity, recorded in seconds. The stopwatch must start from the moment the participant touches the first peg until the last peg touches the container. This assessment requires a board, of wood or plastic, with 9 holes (10 mm diameter, 15 mm depth), spaced 32 mm or 50 mm apart and a stopwatch.
  3. Tenascin-C To perform an ELISA for Tenascin-C, the procedure involves preparing samples and standards according to the kit instructions. The samples and standards are added to wells pre-coated with Tenascin-C-specific antibodies and incubated to facilitate binding. Following incubation, the wells are washed to remove any unbound substances. A detection antibody, conjugated with an enzyme, is then added and incubated. After additional washing, a substrate solution is introduced, causing a color change proportional to the amount of Tenascin-C present. The reaction is stopped with an acid solution, and the optical density is measured using a plate reader. The Tenascin-C concentration in the samples is determined by comparing the optical density readings to a standard curve. Typically, Tenascin-C levels are reported in pg/mL, and the assay range and sensitivity depend on the specific kit used. Accurate interpretation requires comparing the sample values to the standard curve to assess Tenascin-C expression levels, which can provide insights into the biological or pathological state being investigated.

    1. Sample Size

    This clinical trial aims to compare the effectiveness of Robotic Therapy, Exergame Therapy, and Standard Therapy in improving hand function among post-stroke patients. Assuming a standard deviation of 26.75, an expected mean difference of 18.72, and a dropout rate of 30%, the sample size is calculated to be 16 participants per group. This calculation is based on a 95% confidence level (Zα = 1.96) and 80% power (Zβ = 0.84) across the three arms.

    1. Proposed Statistical Analysis

    the data will be analyzed using Analysis of Variance/ ANOVA assuming no difference in baseline characteristic. Next, the relationship between continuous values will be assessed using the Pearson correlation test (normally distributed data) or the Spearman test (data not normally distributed) to determine how big the correlation is between these variables.

03

Conditions studied

  • Stroke
  • Paralysis Arm

Browse trials for

Keywords

  • Robotic Rehabilitation
  • Video-assisted Rehabilitation
  • Post-Stroke
  • Functional Outcome
  • Tenascin-C
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients after ischemic or hemorrhagic stroke
  • stable hemodynamics and neurologic state.
  • Patients have never undergone treatment with any intervention
  • Able to watch television with or without glasses from a distance of 1 meter.
  • Patients can understand to participate in research

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of seizures or epilepsy.
  • Patients with severe cognitive disorders that can interfere with research objectives ( score \<24).
  • Patients with field deficits or severe vision disorders.
  • The patient is unable to sit upright without help.
  • Patients with significant pain in the affected upper limb.
  • Patients with significant sensory decreases in the upper limb that are affected
  • Patients with other medical conditions (musculoskeletal, neuromuscular, cardio respiration) are uncontrolled and are at risk of disrupting the ability to exercise.

Dropout Criteria

  • Patients who were declared dead
  • Refusing to continue the training session or less \< 50% of all sessions.
  • Experiencing hemodynamic and neurological disorders during the training program process.
  • Experiencing cybersickness twice in successive training sessions
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
48 participants (estimated)

Study arms

  • Active comparator
    Standard Rehabilitation/Conventional

    The conventional exercise therapy group will be given diathermic, electricity modality, hydrotherapy, and therapeutic exercises in the form of muscle stretching, strengthening exercises, transfer exercises, walking exercises, and hand function exercises for 3 times a week within 6 weeks.

    Procedure: Conventional

  • Experimental
    Exergame

    Conventional therapy coupled with virtual reality Exergame exercises on the hands for 3 times a week a time 6 weeks

    Procedure: Exergame

  • Experimental
    Robotic

    conventional therapy coupled with robotic therapy exercises on the hands for 3 times a week a time of 6 weeks

    Procedure: Robotic

Interventions

  • ProcedureExergame

    Hand Training assisted with Virtual-Reality

  • ProcedureRobotic

    Hand Training assisted with Robotic Syrebo

  • ProcedureConventional

    Hand Training with Physical Therapist

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score

    a motoric assessment with each score range from 0-2 with a total score range from 0-66. Higher score indicates better and free movement

    Time frame: changes of FMA-UE score from pre-intervention to six weeks after intervention

  2. Nine Hole Peg Test Value

    an assessment for finger dexterity and coordination where the time of the subject to accomplish task will be recorded. Average healthy adult male completed the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand. For healthy adult women, the NHPT was completed in 17.9 seconds (SD 2.8) and 19.6 seconds (SD 3.4) with the right and left hands, respectively.

    Time frame: changes of NHPT values from pre-intervention to six weeks after intervention

  3. Handgrip Dynamometer value

    The handgrip dynamometer measures hand strength, with a typical range of 0 to 100 kg (0 to 220 lb). For men, normal handgrip strength usually falls between 30-60 kg (66-132 lb), while for women it ranges from 20-40 kg (44-88 lb).

    Time frame: changes of handgrip values from pre-intervention to six weeks after intervention

  4. Tenascin-C value

    The normal range of Tenascin-C levels in healthy individuals typically falls between 50 to 200 ng/mL.

    Time frame: changes of Tenascin-C value from pre-intervention to six weeks after intervention

07

Study locations

2 of 2 sites recruiting
  • Hasanuddin University, Faculty of Medicine
    Makassar, South Sulawesi 90245, Indonesia
    Recruiting
    • Auliyah Fadly, MD · Contactmuh.auliyah.fadly@gmail.com · +62411591331
    • Rumaisah Hasan, MD · Principal investigator
    • Yose Waluyo, MD, PhD · Principal investigator
    • Husnul Mubarak, MD, PhD · Principal investigator
    • Nuralam Sam, MD, PhD · Principal investigator
  • Wahidin Sudirohusodo General Hospital
    Makassar, South Sulawesi 90245, Indonesia
    Recruiting
    • Auliyah Fadly · Contactmuh.auliyah.fadly@gmail.com · +62 411 583333
    • Rumaisah Hasan, MD · Principal investigator
    • Nuralam Sam, MD. PhD · Principal investigator
    • Husnul Mubarak, MD · Principal investigator
    • Yose Waluyo, MD, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — No To protect the confidentiality, should the data need to share, any de-identified data will be shared for peer-review

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2024, 14 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 14 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2024
First posted
Aug 20, 2024
StartActual
Oct 1, 2023
Primary completionEst.
Dec 1, 2024
CompletionEst.
Mar 1, 2025
Last update
Aug 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06563206
Lead sponsor
Hasanuddin University
Responsible party
Bumi Herman (Lecturer, Hasanuddin University) — Principal investigator
First posted
Aug 20, 2024
Start date
Oct 1, 2023
Primary completion
Dec 1, 2024 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Aug 20, 2024

Study contacts

Auliyah Fadly, MD
Contact
muh.auliyah.fadly@gmail.com
+6281234328649
Rumaisah Hasan, MD
principal investigator · Hasanuddin University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion